Search research articles
Contact Us
Filters
Showing results (51-60 of 67) with videos related to
Page
of 7
Sort By:
Diabetes
|
December 1, 1996
Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin
N S Fineberg, S E Fineberg, J H Anderson, et al.
The Journal of Laboratory and Clinical Medicine
|
November 1, 1988
Effect of insulin immune complexes on human blood monocyte and endothelial cell procoagulant activity
B Uchman, N U Bang, M J Rathbun, et al.
Neurology
|
July 10, 2002
Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke
L S Williams, J Rotich, R Qi, et al.
Diabetes Care
|
October 17, 1998
Effect of postmenopausal hormone therapy on glucose and insulin concentrations. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions
M A Espeland, P E Hogan, S E Fineberg, et al.
Diabetes Care
|
November 1, 1982
Clinical pharmacologic studies with human insulin (recombinant DNA)
J A Galloway, M A Root, R Bergstrom, et al.
Diabetes Care
|
November 1, 1982
The U.S. "new patient" and "transfer" studies
J A Galloway, F B Peck, S E Fineberg, et al.
Diabetes Care
|
August 1, 1992
Immediate HbA1c results. Performance of new HbA1c system in pediatric outpatient population
D G Marrero, J L Vandagriff, R Gibson, et al.
Diabetes
|
March 1, 1988
Immunologic aspects of human proinsulin therapy
S E Fineberg, M J Rathbun, S Hufferd, et al.
Maturitas
|
July 1, 1997
The Postmenopausal Estrogen/Progestin Interventions Study: primary outcomes in adherent women
E Barrett-Connor, S Slone, G Greendale, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 1, 1997
Effect of postmenopausal hormone therapy on body weight and waist and hip girths. Postmenopausal Estrogen-Progestin Interventions Study Investigators
M A Espeland, M L Stefanick, D Kritz-Silverstein, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 67) with videos related to
Sort By:
Page
of 7
Diabetes
|
December 1, 1996
Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin
N S Fineberg, S E Fineberg, J H Anderson, et al.
The Journal of Laboratory and Clinical Medicine
|
November 1, 1988
Effect of insulin immune complexes on human blood monocyte and endothelial cell procoagulant activity
B Uchman, N U Bang, M J Rathbun, et al.
Neurology
|
July 10, 2002
Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke
L S Williams, J Rotich, R Qi, et al.
Diabetes Care
|
October 17, 1998
Effect of postmenopausal hormone therapy on glucose and insulin concentrations. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions
M A Espeland, P E Hogan, S E Fineberg, et al.
Diabetes Care
|
November 1, 1982
Clinical pharmacologic studies with human insulin (recombinant DNA)
J A Galloway, M A Root, R Bergstrom, et al.
Diabetes Care
|
November 1, 1982
The U.S. "new patient" and "transfer" studies
J A Galloway, F B Peck, S E Fineberg, et al.
Diabetes Care
|
August 1, 1992
Immediate HbA1c results. Performance of new HbA1c system in pediatric outpatient population
D G Marrero, J L Vandagriff, R Gibson, et al.
Diabetes
|
March 1, 1988
Immunologic aspects of human proinsulin therapy
S E Fineberg, M J Rathbun, S Hufferd, et al.
Maturitas
|
July 1, 1997
The Postmenopausal Estrogen/Progestin Interventions Study: primary outcomes in adherent women
E Barrett-Connor, S Slone, G Greendale, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 1, 1997
Effect of postmenopausal hormone therapy on body weight and waist and hip girths. Postmenopausal Estrogen-Progestin Interventions Study Investigators
M A Espeland, M L Stefanick, D Kritz-Silverstein, et al.
Page
of 7